NCT00800800 - Effects of Rosuvastatin on Aortic Stenosis Progression | Biotech Hunter

Enrollment

378

Participants

Timeline

Start Date

November 30, 2002

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions

Aortic Stenosis

Interventions

DRUG

Rosuvastatin

40 mg, oral, single dose

DRUG

Placebo

oral, single dose

Trial Locations (15)

Research site, Calgary

Research site, Edmonton

Research site, Surrey

Research site, Vancouver

Research site, Victoria

Research site, Edmonton

Research site, Brampton

Research site, Cambridge

Research site, Kitchener

Research site, Montreal

Research site, Ottawa

Research site, Toronto

Research site, Montreal

Research site, Halifax

Research site, St. John's